Sachiko Ozawa

Sachiko Ozawa

  • Health Economist, International Vaccine Access Center

  • Departmental Affiliation(s):

    International Health (Primary)
    Division: Health Systems


    PhD, Johns Hopkins University, 2010
    MHS, Johns Hopkins University, 2007


    Research interests include: - Examining the effectiveness & efficiency of healthcare interventions such as vaccines for better resource allocation - Measuring & building people’s trust, social capital, and preferences in healthcare - Improving coverage, access & sustainability of health systems financing interventions to reduce healthcare-driven poverty

    Honors and Awards

    Teaching Excellence Recognition, Johns Hopkins Bloomberg School of Public Health, 2011 & 2012 Faculty Pilot Grants in Global Health, Johns Hopkins Center for Global Health; The Toyota Foundation Research Grant Award, 2010 New Investigator in Global Health, Global Health Council; The Ruth Rice Puffer Fund for International Student Support; Nancy Stephens Student Support Fund, 2009 The Dean’s Teaching Fellowship, Johns Hopkins University; Baker, Reinke, Taylor Scholarship in International Health, 2008 Delta Omega Public Health Honors Society; The Dean’s Alumni Advisory Council Scholarship, Johns Hopkins Bloomberg School of Public Health; Global Field Experience Fund, 2007 Associate in Risk Management, Insurance Institute of America, 2005 Phi Beta Kappa National Honors Society, 2003

    Research Interests

    Health economics, health systems, vaccines, health financing, health insurance, trust, social capital, scale development, economic evaluation, mixed methods, international health


    Most recent publications

    • Ozawa S, Sripad P (2013). How do you measure trust in the health system? A systematic review of the literature. Social Science & Medicine. 91:10-14.
    • Ozawa S, Pongpirul K (2013). 10 Best Resources on Mixed Methods Research in Health Systems. Health Policy & Planning. 2013 Apr 5.
    • Ozawa S, Stack M (2013). Public Trust and Vaccine Acceptance – International Perspectives. Human Vaccines & Immunotherapeutics. Jun 3;9(8).
    • Ozawa S, Mirrelman A, Stack M, Walker D, Levine OS (2012). Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle- Income Countries: A Systematic Review. Vaccine. Dec; 31(1):96-108.
    • Ozawa S, Stack ML, Bishai DM, Mirelman A, Friberg IK, Niessen L, Walker DG, Levine OS (2011). During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Affairs (Millwood). Jun; 30(6):1010-20.